Website
Alcidion Group LimitedTelephone
61.3.8060.6177
Address
Level 10 9 Yarra Street South Yarra, Victoria (VIC) 3141
Description
Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. It provides clinicians with decision support tools and making recommendations about patient care, patient flow and patient safety, organizational efficiency may be optimized and key clinical risks eliminated. It also offers solutions for Emergency Rooms, Inpatient Services and Outpatient Departments. The company was founded by Steven David Crabbe and Stephen James Woods on April 15, 2010 and is headquartered in South Yarra, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.09
Trade Value (12mth)
AU$20,842.00
1 week
5.17%
1 month
8.93%
YTD
-18.67%
1 year
-11.59%
All time high
0.48
EPS 3 yr Growth
190.90%
EBITDA Margin
-9.60%
Operating Cashflow
-$7m
Free Cash Flow Return
-7.90%
ROIC
-9.40%
Interest Coverage
-34.40
Quick Ratio
1.00
Shares on Issue (Fully Dilluted)
1342m
HALO Sector
Technology
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
14 November 24 |
Alcidion secures contract with NALHN
×
Alcidion secures contract with NALHN |
11 November 24 |
Notification regarding unquoted securities - ALC
×
Notification regarding unquoted securities - ALC |
31 October 24 |
Q1 FY25 Quarterly Activities Report and Appendix 4C
×
Q1 FY25 Quarterly Activities Report and Appendix 4C |
28 October 24 |
Alcidion Quarterly Results and Investor Webcast Notification
×
Alcidion Quarterly Results and Investor Webcast Notification |
25 October 24 |
Change of Company Secretary
×
Change of Company Secretary |
23 October 24 |
2024 Annual General Meeting Chair Address & Presentation
×
2024 Annual General Meeting Chair Address & Presentation |
23 October 24 |
Results of 2024 Annual General Meeting
×
Results of 2024 Annual General Meeting |
23 October 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
01 October 24 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
20 September 24 |
2024 Notice of Annual General Meeting
×
2024 Notice of Annual General Meeting |
19 September 24 |
Notification of cessation of securities - ALC
×
Notification of cessation of securities - ALC |
18 September 24 |
Application for quotation of securities - ALC
×
Application for quotation of securities - ALC |
18 September 24 |
Cleansing Notice
×
Cleansing Notice |
29 August 24 |
Alcidion appoints new Non-Executive Director
×
Alcidion appoints new Non-Executive Director |
29 August 24 |
FY24 Appendix 4E
×
FY24 Appendix 4E |
29 August 24 |
FY24 Annual Report
×
FY24 Annual Report |
29 August 24 |
FY24 Results Media Release
×
FY24 Results Media Release |
29 August 24 |
FY24 Results Investor Presentation
×
FY24 Results Investor Presentation |
29 August 24 |
FY24 Appendix 4G
×
FY24 Appendix 4G |
29 August 24 |
FY24 Corporate Governance Statement
×
FY24 Corporate Governance Statement |
22 August 24 |
ALC FY24 Full Year Results and Investor Webcast Notification
×
ALC FY24 Full Year Results and Investor Webcast Notification |
30 July 24 |
Q4 FY24 Quarterly Activities Report and Appendix 4C
×
Q4 FY24 Quarterly Activities Report and Appendix 4C |
25 July 24 |
Alcidion Quarterly Results and Investor Webcast Notification
×
Alcidion Quarterly Results and Investor Webcast Notification |
24 July 24 |
Alcidion Selected as Preferred EPR Supplier by North Cumbria
×
Alcidion Selected as Preferred EPR Supplier by North Cumbria |
17 July 24 |
Long term partnership signed with Hume Rural Health Alliance
×
Long term partnership signed with Hume Rural Health Alliance |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.